U.S. Gastrointestinal Therapeutics Market, 2025-2033
The gastrointestinal therapeutics market in the United States is expected to reach a projected revenue of US$ 15,091.7 million by 2033. A compound annual growth rate of 1.4% is expected of the United States gastrointestinal therapeutics market from 2026 to 2033.
- Pharmaceuticals
- GI therapeutics
- gastrointestinal therapeutics market
- GI therapeutics